Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Approach for chemosensitization of cisplatin-resistant ovarian cancer by cucurbitacin B
Fardous F. El‐Senduny, Farid A. Badria, Ahmed M. El‐Waseef, et al.
Tumor Biology (2015) Vol. 37, Iss. 1, pp. 685-698
Closed Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

Modulating ROS to overcome multidrug resistance in cancer
Qingbin Cui, Jing‐Quan Wang, Yehuda G. Assaraf, et al.
Drug Resistance Updates (2018) Vol. 41, pp. 1-25
Closed Access | Times Cited: 557
Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine
Hua Luo, Chi Teng Vong, Hanbin Chen, et al.
Chinese Medicine (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 446
Role of Phytochemicals in Cancer Prevention
Alok Ranjan, Sharavan Ramachandran, Nehal Gupta, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 20, pp. 4981-4981
Open Access | Times Cited: 315
Pharmacological Effects of Cisplatin Combination with Natural Products in Cancer Chemotherapy
Shaloam Dasari, Sylvianne Njiki, Ariane Mbemi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1532-1532
Open Access | Times Cited: 175
Elucidating Role of Reactive Oxygen Species (ROS) in Cisplatin Chemotherapy: A Focus on Molecular Pathways and Possible Therapeutic Strategies
Sepideh Mirzaei, Kiavash Hushmandi, Amirhossein Zabolian, et al.
Molecules (2021) Vol. 26, Iss. 8, pp. 2382-2382
Open Access | Times Cited: 95
Synergistic effects of natural compounds and conventional chemotherapeutic agents: recent insights for the development of cancer treatment strategies
Ana María Castañeda, Carlos Mario Meléndez, Diego Uribe, et al.
Heliyon (2022) Vol. 8, Iss. 6, pp. e09519-e09519
Open Access | Times Cited: 63
Natural products as chemo-radiation therapy sensitizers in cancers
Sabah Nisar, Tariq Masoodi, Kirti S. Prabhu, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113610-113610
Open Access | Times Cited: 49
Cucurbitacins as potential anticancer agents: new insights on molecular mechanisms
Carla Varela, Catarina Melim, Beatriz Guapo Neves, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 44
Molecular mechanisms of ROS-modulated cancer chemoresistance and therapeutic strategies
Xiaoting Zhou, Biao An, Yi Lin, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115036-115036
Open Access | Times Cited: 38
Modulation of redox homeostasis: A strategy to overcome cancer drug resistance
Li Yang, Xiaoyue Zhang, Zhihan Wang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 30
Understanding the regulatory landscape of protein phosphatase 2A (PP2A): Pharmacological modulators and potential therapeutics
David B. Neale, Jonathan C. Morris, Nicole M. Verrills, et al.
Pharmacology & Therapeutics (2025), pp. 108834-108834
Closed Access | Times Cited: 1
Cucurbitacin B and cancer intervention: Chemistry, biology and mechanisms (Review)
Sukant Garg, Sunil C. Kaul, Renu Wadhwa
International Journal of Oncology (2017)
Open Access | Times Cited: 82
Sensitization of tumor cells to chemotherapy by natural products: A systematic review of preclinical data and molecular mechanisms
Raimundo Gonçalves de Oliveira Júnior, Alves Ferraz Christiane Adrielly, Jackson Roberto Guedes da Silva Almeida, et al.
Fitoterapia (2018) Vol. 129, pp. 383-400
Open Access | Times Cited: 81
Carbon monoxide: An emerging therapy for acute kidney injury
Xiaoxiao Yang, Mark de Caestecker, Leo E. Otterbein, et al.
Medicinal Research Reviews (2019) Vol. 40, Iss. 4, pp. 1147-1177
Open Access | Times Cited: 58
Nutritional, phytochemical compositions and natural therapeutic values of citron watermelon (Citrullus lanatus var. citroides): A Review
Dominic Karane Nkoana, Jacob Mashilo, Hussein Shimelis, et al.
South African Journal of Botany (2021) Vol. 145, pp. 65-77
Open Access | Times Cited: 44
YTHDF3 Facilitates eIF2AK2 and eIF3A Recruitment on mRNAs to Regulate Translational Processes in Oxaliplatin-Resistant Colorectal Cancer
Yang Zhao, Hongchao Zhao, Danhuan Zhang, et al.
ACS Chemical Biology (2022) Vol. 17, Iss. 7, pp. 1778-1788
Closed Access | Times Cited: 30
Drug Repurposing - Hypothesis, Molecular Aspects and Therapeutic Applications
Farid A. Badria, Mithun Rudrapal, Shubham J. Khairnar, et al.
IntechOpen eBooks (2020)
Open Access | Times Cited: 42
Enhancing the chemosensitivity of HepG2 cells towards cisplatin by organoselenium pseudopeptides
Saad Shaaban, Sameh M. Shabana, Yasair S. Al‐Faiyz, et al.
Bioorganic Chemistry (2021) Vol. 109, pp. 104713-104713
Closed Access | Times Cited: 40
Manuka honey, a unique mono-floral honey. A comprehensive review of its bioactives, metabolism, action mechanisms, and therapeutic merits
Fardous F. El‐Senduny, Nesrine M. Hegazi, Ghada G. El‐Bana, et al.
Food Bioscience (2021) Vol. 42, pp. 101038-101038
Closed Access | Times Cited: 39
Cucurbitacin B regulates lung cancer cell proliferation and apoptosis via inhibiting the IL-6/STAT3 pathway through the lncRNA XIST/miR-let-7c axis
Jianhua Liu, Chen Li, Liang Cao, et al.
Pharmaceutical Biology (2021) Vol. 60, Iss. 1, pp. 154-162
Open Access | Times Cited: 39
Recent Advances in the Application of Cucurbitacins as Anticancer Agents
Bartłomiej Zieniuk, Magdalena Pawełkowicz
Metabolites (2023) Vol. 13, Iss. 10, pp. 1081-1081
Open Access | Times Cited: 13
Navigating the redox landscape: reactive oxygen species in regulation of cell cycle
Viktoria Mackova, Martina Raudenská, Hana Polanská, et al.
Redox Report (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 5
Multifaceted Therapeutic Impacts of Cucurbitacin B: Recent Evidences From Preclinical Studies
Mukesh Sahu, Tripti Paliwal, Smita Jain, et al.
Phytotherapy Research (2025)
Closed Access
Cucurbitacin B induces autophagy and apoptosis by suppressing CIP2A/PP2A/mTORC1 signaling axis in human cisplatin resistant gastric cancer cells
Xuewen Liu, Chao Duan, Juanli Ji, et al.
Oncology Reports (2017) Vol. 38, Iss. 1, pp. 271-278
Open Access | Times Cited: 44
Lycopene reduces ovarian tumor growth and intraperitoneal metastatic load.
Nina Pauline Holzapfel, Ali Shokoohmand, Ferdinand Wagner, et al.
PubMed (2017) Vol. 7, Iss. 6, pp. 1322-1336
Closed Access | Times Cited: 39
Page 1 - Next Page

Scroll to top